Weighted Average Number of Shares Outstanding, Basic of AGILE THERAPEUTICS INC from 31 Mar 2014 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
AGILE THERAPEUTICS INC quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2014 to 30 Jun 2024.
  • AGILE THERAPEUTICS INC Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Jun 2024 was 6,856,229, a 287% increase year-over-year.
  • AGILE THERAPEUTICS INC annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 2,156,726, a 399% increase from 2022.
  • AGILE THERAPEUTICS INC annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 432,219, a 791% increase from 2021.
  • AGILE THERAPEUTICS INC annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 48,536, a 98% decline from 2020.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

AGILE THERAPEUTICS INC Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 6,856,229 +5,086,426 +287% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 4,631,902 +3,719,858 +408% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 2,156,726 +1,724,507 +399% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2024 2023 FY
Q3 2023 2,950,136 +2,210,179 +299% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 1,769,803 +1,679,599 +1862% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 912,044 +849,740 +1364% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 432,219 +383,683 +791% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 739,957 -1,603,973 -68% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 90,204 -2,127,145 -96% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 62,304 -2,128,346 -97% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 48,536 01 Oct 2021 31 Dec 2021 10-K 28 Mar 2024 2023 FY
Q3 2021 2,343,930 -85,006,575 -97% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2022 Q3
Q2 2021 2,217,349 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 2,190,650 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q3 2020 87,350,505 01 Jul 2020 30 Sep 2020 10-Q/A 30 Dec 2021 2021 Q3
Q1 2015 21,282,692 +21,176,383 +19920% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2015 2015 Q1
Q1 2014 106,309 01 Jan 2014 31 Mar 2014 10-Q 12 May 2015 2015 Q1

AGILE THERAPEUTICS INC Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 2,156,726 +1,724,507 +399% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2024 2023 FY
2022 432,219 +383,683 +791% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 48,536 -2,068,541 -98% 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2024 2023 FY
2020 2,117,077 -47,315,410 -96% 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2023 2022 FY
2019 49,432,487 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.